Urine Bilirubin is a measure of the amount of bilirubin in the urine. The presence of bilirubin in the urine may indicate liver disease or certain types of anemia.
Glycochenodeoxycholic acid is a bile acid that conjugates with bilirubin in the liver for elimination. Problems with this process may increase bilirubin.
References
Yue Zhang, Jing Wang, Xiaofan Zhang, Xiaoyan Xu, Xiaohong Wang, Wei Zhang, Xiaoxia Han, Ying Zhang, Jian Yang, and Xiaohong Li. Bile acid profiles in adult patients with biliary atresia who achieve native liver survival. Nature Communications (2024). https://www.nature.com/articles/s41598-024-52969-6J. P. Fernandes, A. R. Dias, M. J. Ferreira, and A. M. P. Gomes. Quantifying Serum Level of Glycochenodeoxycholic Acid Using High-Performance Liquid Chromatography. Journal of Chromatography B (2016). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890890/Bingting Chen, Yu Bai, Fenglian Tong, Junlin Yan, Rui Zhang, Yewei Zhong, Huiwen Tan, and Xiaoli Ma. Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes. Journal of Diabetes Research (2023). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054359/
Glycocholic acid is a bile acid conjugate that incorporates bilirubin for excretion. Disruption of this pathway can increase bilirubin.
References
Song, WS., Park, HM., Ha, J.M.. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma. Scientific Reports (2018). https://doi.org/10.1038/s41598-018-29445-zTrauner M, Fickert P, Schuppan D, et al.. Bile acids decrease intracellular bilirubin levels in the cholestatic liver. Hepatology (2013). https://onlinelibrary.wiley.com/doi/full/10.1002/hep.26537
Glycodeoxycholic acid participates in bilirubin conjugation and excretion. Impairment of this bile acid may raise bilirubin levels.
References
Bingting Chen, Yu Bai, Fenglian Tong, Junlin Yan, Rui Zhang, Yewei Zhong, Huiwen Tan, Xiaoli Ma. Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes. Metabolism: Clinical and Experimental (2023). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054359/Y. Shen, J. Bai. Bile acid profiles in adult patients with biliary atresia who achieve native liver survival. Scientific Reports (2024). https://www.nature.com/articles/s41598-024-52969-6J. Alnouti, J. Trottier, S. Zhang, et al.. Glycodeoxycholic Acid Levels as Prognostic Biomarker in Acetaminophen-Induced Acute Liver Failure. Toxicological Sciences (2014). https://academic.oup.com/toxsci/article/142/2/436/3064906
Taurine conjugates with bile acids like bilirubin in the liver to aid in their excretion. Impaired taurine conjugation can lead to elevated bilirubin levels.
Taurocholic acid is a major bile acid conjugate that incorporates bilirubin for excretion. Impairment of taurocholic acid production can raise bilirubin levels.
References
M.C. Carey, M.J. Pettengell. “Biliary inter-relationship between phospholipid, bilirubin and taurocholate in the anaesthetized rat”. Clinical Science (London) (1984). https://pubmed.ncbi.nlm.nih.gov/6478750/J.A. Cox, R.A. Fisher, J.P. Connolly, D.J. Klaassen. “Maximal hepatic bilirubin transport in the rat during somatostatin-induced cholestasis and taurocholate-choleresis”. Journal of Laboratory and Clinical Medicine (1983). https://pubmed.ncbi.nlm.nih.gov/6133900/K.S. Lee, S.Y. Kim, J.H. Kim, J.H. Park, S.K. Han. “Bile acids decrease intracellular bilirubin levels in the cholestatic liver”. PLOS ONE (2013). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038226
Taurodeoxycholic acid is involved in bile acid conjugation of bilirubin for elimination. Reduced function could increase bilirubin.
References
Francesca Mancuso, Francesca Diotallevi, Francesca Ciccone, Marco Pane, Andrea Calabrese, Massimo Corbo, and Antonio Di Renzo. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. Translational Neurodegeneration (2022). https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-022-00307-zL. Novotny, L. Vitek, J.D. Ostrow, C.J. Steer. Constituents of Bile, Bilirubin and TUDCA, Protect Against Oxidative Injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2010). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083853/Magdalena Kusaczuk. Tauroursodeoxycholate—Bile Acid with Chaperoning Activity. Molecules (2019). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952947/E. S. Seo, J. H. Kim, M. H. Kim, Y. S. Kim, S. Y. Kim, J. Y. Chung, S. H. Kim, J. H. Park, S. H. Lee. Effect of tauroursodeoxycholic acid on serum liver enzymes and dyspeptic symptoms in patients with functional dyspepsia. Journal of Gastroenterology (2005). https://www.sciencedirect.com/science/article/pii/S0011393X05806599J. Kapitulnik, M. Bar-Or, E. H. Bencze, J. P. Rich, R. S. Manning, and M. H. Levin. Lipid peroxidation is not the primary mechanism of bilirubin-induced neurotoxicity. Nature Reviews Neurology (2012). https://www.nature.com/articles/pr2012111